Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03426865 | Role of Axumin PET Scan in Germ Cell Tumor(TESTPET) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05202301 | A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | completed | — | 13,779 | BayerINDUSTRY |
| 1 |
| Aug 11, 2025 |
| clinicaltrials |
| NCT04301414 | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer(Neo-Red-P) | completed | Early Phase 1 | 26 | Columbia UniversityOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05137561 | Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP)(PROBIOP) | completed | Phase 2 / Phase 3 | 217 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05585034 | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | completed | Phase 1 | 60 | Xencor, Inc.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05764330 | Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance | completed | N/A | 20 | Roswell Park Cancer InstituteOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT05176756 | RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)(ALLSTAR) | completed | N/A | 150 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT02975934 | A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency(TRITON3) | completed | Phase 3 | 405 | pharmaand GmbHINDUSTRY | 12 | Jul 25, 2025 | clinicaltrials |
| NCT05458856 | Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate(TriptoSwitch) | completed | Phase 3 | 147 | IpsenINDUSTRY | 7 | Jul 25, 2025 | clinicaltrials |
| NCT02425592 | Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)(ASPIRE) | completed | — | 223 | Yale UniversityOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT05544227 | Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 15 | Williams Cancer FoundationOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT04381832 | Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 173 | Arcus Biosciences, Inc.INDUSTRY | 2 | Jul 22, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT03834506 | Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) | completed | Phase 3 | 1,030 | Merck Sharp & Dohme LLCINDUSTRY | 21 | Jul 18, 2025 | clinicaltrials |
| NCT05547386 | 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 163 | Mayo ClinicOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT03448458 | Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 2 | 17 | Emory UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT02430480 | Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2025 | clinicaltrials |
| NCT03963739 | Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer(PCW) | completed | — | 255 | Wake Forest University Health SciencesOTHER | 2 | Jul 16, 2025 | clinicaltrials |
| NCT07069465 | Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging(PIONEER PSMA) | completed | Early Phase 1 | 10 | Urology Clinics of North TexasNETWORK | 1 | Jul 16, 2025 | clinicaltrials |
| NCT02204072 | BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC) | completed | Phase 1 | 120 | Boehringer IngelheimINDUSTRY | 8 | Jul 15, 2025 | clinicaltrials |
| NCT04742361 | Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer | completed | Phase 3 | 136 | ABX advanced biochemical compounds GmbHINDUSTRY | 3 | Jul 15, 2025 | clinicaltrials |
| NCT05877144 | LiSWT for Nerve Sparing Radical Prostatectomy ED | completed | N/A | 8 | Thomas Jefferson UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04531709 | Financial Toxicity and Quality of Life in Patients With TGCT | completed | — | 24 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT02242773 | MRI Based Active Selection for Treatment Trial(MAST) | completed | N/A | 208 | University of MiamiOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT02803437 | Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases | completed | — | 334 | BayerINDUSTRY | 1 | Jul 10, 2025 | clinicaltrials |
| NCT04827446 | Lighting Intervention for Cancer-related Fatigue | completed | N/A | 139 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT00923104 | An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin | completed | — | 61 | National Cancer Institute (NCI)NIH | 1 | Jul 8, 2025 | clinicaltrials |
| NCT03162003 | Irish Programme for Stratified Prostate Cancer Therapy(iPROSPECT) | completed | — | 55 | Cancer Trials IrelandNETWORK | 1 | Jul 8, 2025 | clinicaltrials |
| NCT04621500 | Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans(VitD/RNA-seq) | completed | Phase 2 | 60 | Medical University of South CarolinaOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT06902441 | Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database | completed | — | 52,000 | University Hospital, CaenOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT03741335 | GET FIT Prostate: A Randomized Controlled Exercise Trial | completed | N/A | 284 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT06199986 | DeADT - Living Well With Prostate Cancer(DeADT-LW) | completed | N/A | 50 | University of MichiganOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT03149861 | Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR(PSMA-DOCS) | completed | N/A | 56 | University Health Network, TorontoOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT03982095 | Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer(PCa_LS) | completed | — | 40 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 20, 2025 | clinicaltrials |
| NCT03315871 | Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04400656 | PROState Pathway Embedded Comparative Trial(IP3-PROSPECT) | completed | — | 139 | Imperial College LondonOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT02903368 | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | completed | Phase 2 | 118 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT04100018 | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer(CheckMate 7DX) | completed | Phase 3 | 1,030 | Bristol-Myers SquibbINDUSTRY | 28 | Jun 12, 2025 | clinicaltrials |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 84 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Jun 12, 2025 | clinicaltrials |
| NCT03072238 | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer(IPATential150) | completed | Phase 3 | 1,101 | Hoffmann-La RocheINDUSTRY | 26 | Jun 6, 2025 | clinicaltrials |
| NCT00667069 | Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | completed | Phase 3 | 424 | UNICANCEROTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT02957149 | Platelet Rich Plasma During Radical Prostatectomy | completed | N/A | 24 | Mayo ClinicOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT04853914 | Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound. | completed | N/A | 9 | EDAP TMS S.A.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT07006779 | Effects of Music and Conversation in Prostate Biopsy(TRUS-BX) | completed | N/A | 90 | Bozok UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05735652 | An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel | completed | — | 14 | Boston Scientific CorporationINDUSTRY | 1 | May 30, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 11, 2025source: clinicaltrials